Selegiline, also known as l-deprenyl, is an antidepressant drug used to treat major depressive disorder, Parkinson’s disease, and Alzheimer’s disease. It is a monoamine oxidase inhibitor (MAOI) that has been used since the late 1980s to treat depression. While selegiline has been found to be effective in treating depression, there are some hidden side effects that doctors should be aware of. This article will explore the potential hidden side effects of selegiline and discuss ways to uncover the unknown.
Selegiline is an MAOI that works by blocking the enzyme monoamine oxidase from breaking down certain neurotransmitters, such as dopamine and norepinephrine. This allows these neurotransmitters to remain active in the brain longer, providing a mood boost. Selegiline is generally prescribed to treat major depressive disorder, Parkinson’s disease, and Alzheimer’s disease.
While selegiline has been found to be effective in treating depression, there are some hidden side effects that doctors should be aware of. The most common side effects of selegiline are nausea, vomiting, headache, insomnia, dry mouth, dizziness, and constipation. Other potential hidden side effects include anxiety, irritability, confusion, agitation, and hallucinations. Selegiline can also cause an increase in blood pressure and heart rate, which can be dangerous for those with pre-existing heart conditions.
Certain factors can increase the risk of experiencing hidden side effects from selegiline. These include age, gender, weight, and other medications being taken. Elderly patients are more likely to experience hidden side effects from selegiline, as they may have a lower tolerance for the drug. Women are also more likely to experience hidden side effects than men. Those who are overweight or obese may be more likely to experience hidden side effects due to the increased metabolism of the drug. Finally, those who are taking other medications may be more likely to experience hidden side effects due to potential drug interactions.
Due to the potential for hidden side effects, it is important for doctors to take steps to uncover the unknown. One way to do this is to discuss the potential side effects of selegiline with patients before they start taking the medication. It is also important to monitor patients closely while they are taking the medication, as this can help to identify any potential hidden side effects. Finally, doctors should be aware of any potential drug interactions and discuss them with patients before prescribing selegiline.
Selegiline is an effective treatment for major depressive disorder, Parkinson’s disease, and Alzheimer’s disease. However, there are some potential hidden side effects that doctors should be aware of. By discussing the potential side effects of selegiline with patients before they start taking the medication, monitoring patients closely while they are taking the medication, and being aware of any potential drug interactions, doctors can help to uncover the unknown and ensure that patients receive the best possible care.
1.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
2.
GuCS: Genitourinary Cancers Symposium
3.
Obesity-associated cancers tripled nationwide over past two decades
4.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
5.
EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.
1.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
2.
Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment
3.
How to Manage Dic with the Right Treatment Approach
4.
Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights
5.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
Comprehensive Update on Hematology
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation